1. Home
  2. AEF vs EBS Comparison

AEF vs EBS Comparison

Compare AEF & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Emerging Markets Equity Income Fund Inc.

AEF

abrdn Emerging Markets Equity Income Fund Inc.

N/A

Current Price

$7.22

Market Cap

338.2M

Sector

Finance

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.16

Market Cap

303.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEF
EBS
Founded
1989
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.2M
303.3M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
AEF
EBS
Price
$7.22
$5.16
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
104.9K
★ 917.9K
Earning Date
01-01-0001
11-02-2026
Dividend Yield
★ 7.13%
N/A
EPS Growth
N/A
★ 125.83
EPS
★ 0.57
N/A
Revenue
N/A
★ $742,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.03
P/E Ratio
$13.00
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.41
$4.36
52 Week High
$10.14
$14.06

Technical Indicators

Market Signals
Indicator
AEF
EBS
Relative Strength Index (RSI) 28.82 28.53
Support Level $6.88 $4.36
Resistance Level $10.07 $7.18
Average True Range (ATR) 0.23 0.44
MACD -0.02 -0.09
Stochastic Oscillator 1.94 5.06

Price Performance

Historical Comparison
AEF
EBS

About AEF abrdn Emerging Markets Equity Income Fund Inc.

ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a non-diversified closed-end, management investment company. Its investment objective is to seek to provide both current income and long-term capital appreciation. Under normal circumstances, the fund invests a majority of its net assets (plus any borrowings for investment purposes) in emerging markets (excluding China) equity securities. The performance of the fund is measured against the MSCI Emerging Markets ex-China Index. Its investment portfolio consists of equity securities from emerging market companies (excluding China), spanning multiple sectors such as Information Technology, Financials, Industrials, Consumer Discretionary, Real Estate, and others.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: